Bradley Herring - Jan 8, 2024 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Financial Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jan 8, 2024
Transactions value $
-$37,147
Form type
4
Date filed
1/10/2024, 08:01 PM
Previous filing
Jan 9, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale -$18.4K -2K -0.93% $9.23 214K Jan 8, 2024 Direct F1, F2
transaction ENFN Class A Common Stock Sale -$18.7K -2.09K -0.98% $8.95 212K Jan 9, 2024 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.17 to $9.34. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.82 to $9.11. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.